# Nova-Tech Inc. - Inspection Records

Source: https://www.keypedia.com/companies/nova-tech-inc/fe5c85d8-9a42-4481-bdf4-1df3773fe907

> Inspection records and compliance data for Nova-Tech Inc. in Grand Island, Nebraska. Access full analysis and detailed observations.

---

## Details

- Name: Nova-Tech Inc.
- FEI Number: 1931182
- City: Grand Island
- State: Nebraska
- Country Name: United States
- Address Line 1: 4705 Gold Core Rd
- Zip Code: 68801

## Related Documents

- [FDA Inspection 1305228 - Nova-Tech Inc. - 2026-02-04](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/75addad7-be1d-4e4c-9b9d-5b502e0fad0a) — source: FDA, date: February 4, 2026
- [FDA Inspection 1305228 - Nova-Tech Inc. - 2026-02-04](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/0fac94b1-9b0f-43a7-ab9b-17e34a817120) — source: FDA, date: February 4, 2026
- [FDA Inspection 1305228 - Nova-Tech Inc. - 2026-02-04](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/6948065f-9aa9-498b-a509-f16edc00df7c) — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2026
- [FDA Inspection 1305228 - Nova-Tech Inc. - 2026-02-04](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/2e392fd6-cd31-4f3f-9b2a-ffc0ccf31107) — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2026
- [483 - Nova-Tech Inc. - 2023-05-12](https://www.keypedia.com/records/483/nova-tech-inc/4552675c-5ed2-454a-abe8-0276e011dbc8) — source: FDA, date: May 12, 2023
- [FDA Inspection 1205307 - Nova-Tech Inc. - 2023-05-12](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/6bfdaccb-4954-49e7-a70a-ca0ecbd09924) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 12, 2023
- [483 - Nova-Tech Inc. - 2022-03-15](https://www.keypedia.com/records/483/nova-tech-inc/f750f29d-8fda-4632-b79d-393ff7e46cb3) — source: FDA, date: March 15, 2022
- [FDA Inspection 1166232 - Nova-Tech Inc. - 2022-03-15](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/d4735367-46e5-4f18-86d5-a490c1bf2f09) — classification: Official Action Indicated (OAI), source: FDA, date: March 15, 2022
- [FDA Inspection 1166232 - Nova-Tech Inc. - 2022-03-15](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/f8c8286d-927e-4f5d-b1bb-632078ac6646) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2022
- [EIR - Nova-Tech Inc. - 2016-04-22](https://www.keypedia.com/records/eir/nova-tech-inc/73ace4a2-d335-4264-a007-72dd7b1af673) — source: FDA, date: April 22, 2016
- [FDA Inspection 977689 - Nova-Tech Inc. - 2016-04-22](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/8aaf75eb-9ec0-435e-b76a-59f4865ebafe) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 22, 2016
- [FDA Inspection 831843 - Nova-Tech Inc. - 2013-05-08](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/e66ba2ca-8895-40e7-9d42-091549dd8bd0) — classification: No Action Indicated (NAI), source: FDA, date: May 8, 2013
- [FDA Inspection 751988 - Nova-Tech Inc. - 2011-10-21](https://www.keypedia.com/records/fda_inspections/nova-tech-inc/82d68ae7-cec4-4f3a-914d-4320c23bb6f1) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2011

## Related Companies

- [Eriochem SA](https://www.keypedia.com/companies/eriochem-sa/e2f01909-c1a5-49e0-a736-041a0c65beba)
- [Baxalta Manufacturing Sarl](https://www.keypedia.com/companies/baxalta-manufacturing-sarl/71d79fb0-4c45-4139-b2d0-a6e38551344e)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177)
- [Allergan Sales, LLC](https://www.keypedia.com/companies/allergan-sales-llc/1c953156-6298-4351-8d2d-bc0fa979d4eb)
- [Syngene International Ltd.](https://www.keypedia.com/companies/syngene-international-ltd/11ddfe19-cf6b-48b5-b7ab-8e3236ac3636)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)
- [AbbVie Bioresearch Center](https://www.keypedia.com/companies/abbvie-bioresearch-center/6957449c-4de8-444b-b53c-5838b33a76a1)
- [Baxalta US Incorporated](https://www.keypedia.com/companies/baxalta-us-incorporated/bb2b5b07-7c9c-4fce-b969-4dc5fa402b64)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/86ee0564-73c3-4575-acbc-56fb8e87627c)
- [Sun Pharmaceutical Industries Limited](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/51c5d6b8-303e-4e32-bbef-eaca05e879ef)

## Related Officers

- [recipient](https://www.keypedia.com/people/teresa-a-grabowski/340858e4-98e0-4420-8ce5-bf8e217e6680)
- [Pharmaceutical Specialist/ Investigator ](https://www.keypedia.com/people/veronica-fuentes/50ea657f-39e6-4d97-a627-86339df3fbe6)
- [Susanna E. Ford](https://www.keypedia.com/people/susanna-e-ford/4332d436-f50b-4657-9d85-93c10bfe0cc8)
- [Consumer Safety Officer/ Federal Investigator](https://www.keypedia.com/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)
- [Regulatory Officer ](https://www.keypedia.com/people/jill-tillman/4fd81eed-0de2-468b-a776-d4809fa91553)